Fabienne Lebrun

4.7k total citations · 1 hit paper
42 papers, 1.2k citations indexed

About

Fabienne Lebrun is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Fabienne Lebrun has authored 42 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 16 papers in Pulmonary and Respiratory Medicine and 14 papers in Molecular Biology. Recurrent topics in Fabienne Lebrun's work include Cancer Treatment and Pharmacology (12 papers), Advanced Breast Cancer Therapies (11 papers) and HER2/EGFR in Cancer Research (8 papers). Fabienne Lebrun is often cited by papers focused on Cancer Treatment and Pharmacology (12 papers), Advanced Breast Cancer Therapies (11 papers) and HER2/EGFR in Cancer Research (8 papers). Fabienne Lebrun collaborates with scholars based in Belgium, France and United States. Fabienne Lebrun's co-authors include Martine Piccart, Gabriel N. Hortobágyi, Hope S. Rugo, Patrick Neven, Howard A. Burris, Ines Deleu, Michael Gnant, Kathleen I. Pritchard, Shinzaburo Noguchi and Mario Campone and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Cancer Research.

In The Last Decade

Fabienne Lebrun

40 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Everolimus plus exemestane for hormone-receptor-positive, human epidermal growth factor receptor-2-negative advanced breast cancer: overall survival results from BOLERO-2

2014 407 citations Martine Piccart, Gabriel N. Hortobágyi et al. Annals of Oncology profile →

Peers

Countries citing papers authored by Fabienne Lebrun

Since Specialization

Citations

This map shows the geographic impact of Fabienne Lebrun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fabienne Lebrun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fabienne Lebrun more than expected).

Fields of papers citing papers by Fabienne Lebrun

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fabienne Lebrun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fabienne Lebrun. The network helps show where Fabienne Lebrun may publish in the future.

Co-authorship network of co-authors of Fabienne Lebrun

This figure shows the co-authorship network connecting the top 25 collaborators of Fabienne Lebrun. A scholar is included among the top collaborators of Fabienne Lebrun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fabienne Lebrun. Fabienne Lebrun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Lobular Breast Carcinoma with an Isolated Bladder Metastasis: A Case Report 2024 ·European Journal of Medical and Health Sciences ·(unknown), Aspasia Georgala, Fabienne Lebrun, Michail Ignatiadis, (unknown)	0
2	A Rare Case of Hepatic Vanishing Bile Duct Syndrome Occurring after Combination Therapy with Nivolumab and Cabozantinib in a Patient with Renal Carcinoma 2022 ·Diagnostics ·(unknown), (unknown), Soizic Garaud, Joseph Kerger, (unknown), Aspasia Georgala, Fabienne Lebrun, María Gómez Galdón, Thierry Gil, Karen Willard‐Gallo, (unknown)	6
3	Intravenous iron therapy for anemic cancer patients: a review of recently published clinical studies 2017 ·Supportive Care in Cancer ·Fabienne Lebrun, Jean Klášterský, (unknown), (unknown), Marianne Paesmans	21
4	Bosutinib in Combination With the Aromatase Inhibitor Letrozole: A Phase II Trial in Postmenopausal Women Evaluating First-Line Endocrine Therapy in Locally Advanced or Metastatic Hormone Receptor-Positive/HER2-Negative Breast Cancer 2014 ·The Oncologist ·Beverly Moy, Patrick Neven, Fabienne Lebrun, Meritxell Bellet, Binghe Xu, Tomasz Sarosiek, Louis W.C. Chow, Paul E. Goss, Charles Zacharchuk, Eric Leip, Kathleen Turnbull, Nathalie Bardy‐Bouxin, Ladan Duvillié, István Láng	25
5	[Anemia in the critically ill child and adult: a narrative review]. 2014 ·PubMed ·Pierre Demaret, Isabelle Loeckx, Arend Mulder, (unknown), Fabienne Lebrun	0
6	Phase I trial combining temozolomide plus lapatinib for the treatment of brain metastases in patients with HER2-positive metastatic breast cancer: the LAPTEM trial 2013 ·Annals of Oncology ·Evandro de Azambuja, Dimitrios Zardavas, Marc Lemort, José Roberto Freitas Rossari, (unknown), (unknown), Véronique D’Hondt, Fabienne Lebrun, Yassine Lalami, Fátima Cardoso, Christos Sotiriou, Thierry Gil, Daniel Devriendt, Marianne Paesmans, Martine Piccart, Ahmad Awada	21
7	Everolimus plus exemestane as first-line therapy in HR+, HER2− advanced breast cancer in BOLERO-2 2013 ·Breast Cancer Research and Treatment ·J. Thaddeus Beck, Gabriel N. Hortobágyi, Mario Campone, Fabienne Lebrun, Ines Deleu, Hope S. Rugo, Barbara Pistilli, Norikazu Masuda, Lowell L. Hart, Bohuslav Melichar, Shaker R. Dakhil, Matthias Geberth, (unknown), Daniel Y.C. Heng, Thomas Brechenmacher, Mona El-Hashimy, (unknown), François Ringeisen, Martine Piccart	75
8	AUTOIMMUNE HAEMOLYTIC ANAEMIA IN A PATIENT TREATED WITH CAPECITABINE 2013 ·Acta Clinica Belgica ·Spyridon Sideris, Angela Loizidou, Aspasia Georgala, Fabienne Lebrun, Thierry Gil, (unknown), (unknown), Fátima Cardoso	3
9	Health‐related quality of life of patients with advanced breast cancer treated with everolimus plus exemestane versus placebo plus exemestane in the phase 3, randomized, controlled, BOLERO‐2 trial 2013 ·Cancer ·Howard A. Burris, Fabienne Lebrun, Hope S. Rugo, J. Thaddeus Beck, Martine Piccart, Patrick Neven, José Baselga, Katarína Petráková, Gabriel N. Hortobágyi, (unknown), E. Chouinard, Robyn R. Young, Michael Gnant, Kathleen I. Pritchard, L. Michelle Bennett, (unknown), (unknown), Tetiana Taran, Tarek Sahmoud, Shinzaburo Noguchi	72
10	Phase I trial to investigate the safety, pharmacokinetics and efficacy of sorafenib combined with docetaxel in patients with advanced refractory solid tumours 2012 ·European Journal of Cancer ·Ahmad Awada, Alain Hendlisz, Olaf Christensen, Chetan Lathia, S. Bartholomeus, Fabienne Lebrun, Dominique de Valeriola, E. Brendel, Martin Radtke, Thierry Delaunoit, Martine Piccart, Thierry Gil	20
11	AKT1 Inhibits Homologous Recombination by Inducing Cytoplasmic Retention of BRCA1 and RAD51 2008 ·Cancer Research ·Isabelle Plo, Corentin Laulier, Laurent Gauthier, Fabienne Lebrun, Fabien Calvo, Bernard S. López	108
12	Oxaliplatin/5fluorouracil-based chemotherapy was active and well tolerated in heavily pretreated patients with ovarian carcinoma 2008 ·Archives of Gynecology and Obstetrics ·Daniela D. Rosa, Ahmad Awada, Max S. Mano, J. Selleslags, Fabienne Lebrun, Thierry Gil, Martine Piccart, Véronique D’Hondt	12
13	Monoclonal Antibody-Based Targeted Therapy in Breast Cancer 2006 ·Drugs ·Chantal Bernard-Marty, Fabienne Lebrun, Ahmad Awada, Martine Piccart	60
14	Maintenance of differentiation capacity of HT-29 cells after radiation exposure 2005 ·International Journal of Radiation Biology ·Céline Haton, Fabienne Lebrun, Marc Benderitter, Nina M. Griffiths	3
15	Bax and Bid, two proapoptotic Bcl-2 family members, inhibit homologous recombination, independently of apoptosis regulation 2005 ·Oncogene ·Anne Dumay, Corentin Laulier, Pascale Bertrand, Yannick Saintigny, Fabienne Lebrun, (unknown), Bernard S. López	33
16	Functional and structural alterations of epithelial barrier properties of rat ileum following X-irradiation 2004 ·Canadian Journal of Physiology and Pharmacology ·Isabelle Dublineau, Fabienne Lebrun, Stéphane Grison, Nina M. Griffiths	19
17	Modified Absorptive and Secretory Processes in the Rat Distal Colon after Neutron Irradiation: In Vivo and In Vitro Studies 1999 ·Radiation Research ·Agnès François, Isabelle Dublineau, Fabienne Lebrun, Brigitte Ksas, Nina M. Griffiths, (unknown)	11
18	A study of GABAergic system in scrapie-infected hamsters after striatal microinoculation of the agent 1993 ·Neuroscience Letters ·(unknown), Fabienne Lebrun, (unknown), G Salamon, (unknown)	7
19	A Specific Trarisduction Mechanism for the Glutamate Action on Phosphoinositide Metabolism via the Quisqualate Metabotropic Receptor in Rat Brain Synaptoneurosomes: I. External Na⁺ Requirement 1991 ·Journal of Neurochemistry ·Janique Guiramand, Michel Vignes, Ebrahim Mayat, Fabienne Lebrun, (unknown), Max Récasens	64
20	Cholinergic agonists increase cell calcium in rat medullary collecting tubules 1990 ·Pflügers Archiv - European Journal of Physiology ·Jeannine Marchetti, Shigeo Taniguchi, Fabienne Lebrun, (unknown)	13

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact